The only study to include PMS2 carriers (n = 40) found that carriers of the G-alleles of rs10795668 (10p14) and rs9929218 (16q22.1) were at lower risk of CRC, a notable finding in that this is the opposite effect compared to sporadic CRC [7]. Here, PMS2 is linked to colorectal carcinoma.